Sign In
Buy ASLN
$0.600
+0 (+0%)
At Close: Oct 17, 2024
ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares
06:00am, Tuesday, 03'rd Dec 2019
ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has priced its previously announced underwritten pub
Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
05:50pm, Monday, 02'nd Dec 2019
ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has commenced an underwritten public offering of its Americ
